209 related articles for article (PubMed ID: 2799537)
1. [Trofopar treatment of chronic diffuse diseases of the liver].
Loginov AS; Nikolaeva AP; Bendikov EA; Blok IuE; Sukhareva GV
Sov Med; 1989; (7):79-81. PubMed ID: 2799537
[No Abstract] [Full Text] [Related]
2. Trofopar treatment of chronic liver diseases.
Loghinov AS; Suhareva GV; Bendikov EA; Blok IE; Astasenkova CJ; Nicolaeva AP
Rom J Intern Med; 1991; 29(1-2):65-74. PubMed ID: 1947713
[TBL] [Abstract][Full Text] [Related]
3. [Use of "Essenciale" in the treatment of liver diseases].
Pogromov AP; Ol'binskaia LI; Antonenko NI; Gitel' NP; Smolianitskiĭ AIa
Klin Med (Mosk); 1978 Oct; 56(10):97-101. PubMed ID: 362064
[No Abstract] [Full Text] [Related]
4. [Treatment of chronic diseases of the liver with catergen].
Loginov AS; Dzhalalov KD; Blok IuE; Bendikov EA; Ausheva LKh
Ter Arkh; 1986; 58(2):73-6. PubMed ID: 3704945
[TBL] [Abstract][Full Text] [Related]
5. [Hepason in the treatment of hepatocellular diseases].
Stazka Z; Korolko A
Pol Tyg Lek; 1970 Jul; 25(28):1062-4. PubMed ID: 5451158
[No Abstract] [Full Text] [Related]
6. [Alphamercaptopropionylglycine in chronic hepatopathies].
Cacciari G; Malaguti P; Zincati GC
Policlinico Med; 1972; 79(3):165-73. PubMed ID: 5051108
[No Abstract] [Full Text] [Related]
7. [Immunomodulating drugs, thymalin and T-activin in the treatment of chronic liver diseases].
Iakhontova OI; Dudanova OP; Khavinson VKh
Sov Med; 1990; (6):85-8. PubMed ID: 2396134
[No Abstract] [Full Text] [Related]
8. [Use of ornithine carbamoyltransferase in the treatment of liver diseases].
Caruso N; De Jacobis M; Roccato M; Sequino A; Sgoifo B; Tinello M
Clin Ter; 1984 Jul; 110(1):37-44. PubMed ID: 6237844
[No Abstract] [Full Text] [Related]
9. [Treatment of liver cirrhosis and chronic liver diseases with total liver extract].
Borgo E
Minerva Med; 1965 Nov; 56(88):3735-9. PubMed ID: 5846626
[No Abstract] [Full Text] [Related]
10. [Trial of LL 650 in various hepatic diseases].
Savoye B; Dietsch R; Chapuy M; Girard M
J Med Lyon; 1972 May; 53(228):675-6 passim. PubMed ID: 5084113
[No Abstract] [Full Text] [Related]
11. [Use of liver hydrolysates and corticosteroids in chronic hepatitis and liver cirrhosis].
Bakulenko EF
Vrach Delo; 1976 Apr; (4):108-10. PubMed ID: 1007172
[No Abstract] [Full Text] [Related]
12. [Use of a titrated extract of Centella asiatica in chronic hepatic disorders (author's transl)].
Darnis F; Orcel L; de Saint-Maur PP; Mamou P
Sem Hop; 1979 Nov 8-15; 55(37-38):1749-50. PubMed ID: 230597
[TBL] [Abstract][Full Text] [Related]
13. [Clinical study of the effect of the administration of cathergen preparation in patients with chronic hepatic lesions].
Maleev A; Tsvetkova V; Krŭstev Z; Kostova N; Lukanov L
Vutr Boles; 1985; 24(5):39-43. PubMed ID: 4090451
[No Abstract] [Full Text] [Related]
14. [Lecithin-cholesterol-acyltransferase activity in chronic liver diseases].
Gaskina TK; Dolgov AV; Kurilovich SA
Vopr Med Khim; 1987; 33(4):96-9. PubMed ID: 3660750
[TBL] [Abstract][Full Text] [Related]
15. [Preparations of alpha-lipoic acid: the dynamics of their content in the blood and their effect on hemostasis in lesions of the human liver].
Loginov AS; Nilova TV; Bendikov EA; Petrakov AV
Farmakol Toksikol; 1990; 53(2):47-50. PubMed ID: 2115010
[TBL] [Abstract][Full Text] [Related]
16. [Clinical experience in the treatment of chronic liver diseases with Solcohepsyl extralysate].
Arias Vallejo E
Folia Clin Int (Barc); 1966 Sep; 16(9):404-15. PubMed ID: 5990974
[No Abstract] [Full Text] [Related]
17. Studies on the effect of a liver hydrolysate on the hepatic circulation in chronic liver diseases.
Obayashi A; Akioka H; Tazaki H
Arzneimittelforschung; 1972 Mar; 22(3):578-80. PubMed ID: 5067932
[No Abstract] [Full Text] [Related]
18. [On the problem of effects and side effects of steroids and liver hydrolysates in acute and chronic liver diseases].
Kleine FD
Z Arztl Fortbild (Jena); 1966 Aug; 60(15):900-4. PubMed ID: 5995281
[No Abstract] [Full Text] [Related]
19. [A new therapy of hepatic insufficiency. Experiments with (+)-3--cyanidanol. Its importance in the treatment of alcoholic hepatitis].
Traissac FJ; Borg R
Minerva Dietol Gastroenterol; 1977; 23(3):237-42. PubMed ID: 372845
[No Abstract] [Full Text] [Related]
20. Effect of Catergen [(+)cyanidanol-3] on some haemostatic parameters in chronic liver diseases.
Pfliegler G; Boda Z; Dalmi L; Weisz G; Misz M; Beck P
Ther Hung; 1984; 32(1):19-25. PubMed ID: 6571189
[No Abstract] [Full Text] [Related]
[Next] [New Search]
